跳至主要内容
临床试验/NCT00666237
NCT00666237已完成4 期

Primary Tube Versus Trabeculectomy Study

University of Miami16 个研究点 分布在 3 个国家目标入组 242 人开始时间: 2008年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
242
试验地点
16
主要终点
Number of Participants With Surgical Failure

研究概览

简要总结

The purpose of the Primary Tube Versus Trabeculectomy (PTVT) Study is to compare the long-term safety and efficacy of nonvalved tube shunt surgery to trabeculectomy with mitomycin C in eyes that have not had previous ocular surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-85 years
  • Glaucoma that is inadequately controlled on tolerated medical therapy with Intraocular Pressure (IOP) greater than or equal to 18 mm Hg and less than or equal to 40 mm Hg
  • No previous incisional ocular surgery

排除标准

  • Unwilling or unable to give consent, unwilling to accept randomization, or unable to return for scheduled protocol visits
  • Pregnant or nursing women
  • No light perception vision
  • Active iris neovascularization or active proliferative retinopathy
  • Iridocorneal endothelial syndrome
  • Epithelial or fibrous ingrowth
  • Chronic or recurrent uveitis
  • Steroid-induced glaucoma
  • Severe posterior blepharitis
  • Unwilling to discontinue contact lens use after surgery
  • Previous cyclodestructive procedure
  • Conjunctival scarring from prior ocular trauma or cicatrizing disease precluding a superior trabeculectomy
  • Functionally significant cataract
  • Need for glaucoma surgery combined with other ocular procedures or anticipated need for additional ocular surgery

研究组 & 干预措施

Tube shunt surgery group

Experimental

Participants in this group will receive a tube shunt surgery (Baerveldt Glaucoma implant).

干预措施: Tube shunt surgery (Procedure)

Trabeculectomy with Mitomycin C

Experimental

Participants in this group will receive a Trabeculectomy surgery with Mitomycin C

干预措施: Trabeculectomy (Procedure)

Trabeculectomy with Mitomycin C

Experimental

Participants in this group will receive a Trabeculectomy surgery with Mitomycin C

干预措施: Mitomycin C (Drug)

结局指标

主要结局

Number of Participants With Surgical Failure

时间窗: Up to 5 years

Surgical failure is defined as: 1. Inadequate Intraocular Pressure (IOP) Reduction (IOP \> 21 mmHg or reduced \< 20% below baseline on 2 consecutive follow-up visits after 3 months) 2. Reoperation for glaucoma 3. Persistent hypotony (IOP ≤ 5 mmHg on 2 consecutive visits after 3 months) 4. Loss of light perception vision

次要结局

  • Visual Acuity as Measured Using EDTRS Chart(At baseline, At 5 years)
  • Visual Field(Up to 5 years)
  • Reoperation for Glaucoma(Up to 5 years)
  • Number of Participants With Reported Postoperative Complications(Up to 5 years)
  • Intraocular Pressure(At baseline, At 1 year, At 18 months, At 2 years, At 3 years, At 4 years, At 5 years)
  • Visual Acuity Using a Snellen Chart(At Baseline, At 5 years)
  • Number of Glaucoma Medications(At Baseline, At 1 year, At 18 months, At 2 years, At 3 years, At 4 years, At 5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven J. Gedde

Dr

University of Miami

研究点 (16)

Loading locations...

相似试验